In other meta-analysis performed by Zhu et al. [3], based on 34 studies, event-free survival (EFS), OS, and BCSS were compared in three groups of breast cancer patients: BRCA1 carriers, BRCA2 carriers, and BRCA1/2 noncarriers. Here, BRCA2 is linked to breast carcinoma.